Le Lézard
Classified in: Health, Business
Subjects: ECO, POL, CPG, CFG

The governments of Canada and Yukon work together to increase access to treatment options for people with substance use disorders


OTTAWA, Dec. 17, 2018 /CNW/ - The opioid crisis is devastating individuals, families and communities across the country. Without increased access to effective, evidence-based treatment options, people with substance use disorder will continue to be at risk for overdose.

Today, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, Member of Parliament, the Honourable Larry Bagnell and the Honourable Pauline Frost, Yukon's Minister of Health and Social Services, announced a bilateral agreement under the Government of Canada's Emergency Treatment Fund.

The agreement provides more than $945,000?$500,000 from the Government of Canada and $445,104 from Yukon Territory?to increase access to quality treatment services for people with substance use disorder.

This funding will be used to improve, integrate and increase services provided by Yukon's Opioid Treatment Service (OTS). This includes:

The governments of Canada and Yukon will continue to work together to increase treatment services for people who are seeking help for substance use disorders.

Quotes

"Opioid-related overdoses continue to have a devastating impact in communities across Canada, including in Yukon. This bilateral agreement will facilitate and increase access to essential treatment services in the territory to help people with substance use disorder. We must continue to work in a comprehensive and collaborative way to help Canadians access treatment and supports."

The Honourable Larry Bagnell
Member of Parliament

"Yukon has been deeply affected by the opioid crisis and it continues to impact communities across the territory. This funding will increase and improve the services and treatment options available to those with substance use disorders in Yukon. Enhancing our support systems and integrating more long-term strategies around opioid use will help to reduce the harmful impacts on communities in our territory."

The Honourable Pauline Frost
Minister of Health and Social Services, Yukon

Related Products
Backgrounder: Bilateral Agreement between the Government of Canada and the Government of Yukon under the Emergency Treatment Fund 
Emergency Treatment Fund

Associated Links

Infographic: Government of Canada ? Federal Actions on Opioids 
National report: Apparent opioid-related deaths in Canada 

 

SOURCE Health Canada


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: